Company Overview
Snapshot
Founded in January 2006 by Gila Maor, CartiCure operates with 1–10 employees. The company is in the Pre-Funding stage, focusing on developing cartilage repair products. In 2006, CartiCure developed a technology that generates original hyaline cartilage-producing cells for transplantation into damaged joints.
Business overview
CartiCure is an early-stage Health Tech & Life Sciences company specializing in medical devices and medical treatment & therapeutics. The company develops cartilage repair products, with its core technology centered on generating original hyaline cartilage-producing cells for transplantation into damaged joints. CartiCure's initial product, Cartimove, targets knee cartilage damage from trauma injuries, with a subsequent product aimed at the osteoarthritis market. The company serves the healthcare and medical devices industries, particularly providers and medical equipment sectors, with a primary market in the United States.
Log in to access full profile ›Company Intelligence Q&A
- When was CartiCure founded?
- CartiCure was founded in January 2006.
- Who is the founder of CartiCure?
- Gila Maor is the founder and CTO of CartiCure.
- What is CartiCure's primary focus?
- CartiCure is dedicated to the development of cartilage repair products, utilizing a technological platform that generates original hyaline cartilage-producing cells.
- What is CartiCure's first product?
- CartiCure's first product, Cartimove, is designed for the treatment of knee cartilage damage resulting from trauma injuries.
- What is the status of CartiCure's pre-clinical studies?
- CartiCure has successfully completed pre-clinical studies performed in large and small animals.